Single-dose prulifloxacin versus single-dose pefloxacin in the treatment of acute uncomplicated urinary tract infection in women

Urogynaecologia International Journal

Volumn 17, Issue 2, 2003, Pages 69-77

  Cervigni, M ^a   Orticelli, G ^b   Bologna, M ^a   Natale, F ^a   Salvatori, E ^b   Di Loreto, G ^b   Dionisio, Paolo ^b,c  

^a San Carlo Hospital   (Italy)

^b Angelini ACRAF SPalomba Pomezia   (Italy)

^c ACRAF SPA   (Italy)

Author keywords

Acute uncomplicated UTIs; Pefloxacin; Prulifloxacin; Single dose

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; GATIFLOXACIN; PEFLOXACIN; PRULIFLOXACIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ERADICATION THERAPY; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTPATIENT; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REINFECTION; STOMACH PAIN; SUPERINFECTION; TREATMENT OUTCOME; URINARY TRACT INFECTION;

EID: 1542619770     PISSN: 11213086     EISSN: None     Source Type: Journal    
DOI: 10.4081/uij.2003.69     Document Type: Article

References (23)

1. SANDFORD J.P.: Urinary tract symptoms in infections. Ann Rev Med 1975; 26: 485-98.
2. VALIQUETTE L.: Urinary tract infections in women. Can J Urol 2001; 8 Suppl 1: 6-12
3. BENT S., NALLAMOTHU B.K., SIMEL D.L., FIHN S.D., SAINT S.: Does this woman have an acute uncomplicated urinary tract infection? JAMA 2002; 287(20):2701-10
4. BENT S., SAINT S.: The optimal use of diagnostic testing in women with acute uncomplicated cystitis. Am J Med 2002; 113 Suppl 1A: 20S-28S
5. GRÜNEBERG R.N., BRUMFITT W.: Single-dose treatment of acute urinary tract infection. Br Med J 1967; 3: 649-51.
6. BAILEY R.R.: Review of published studies on single-dose theraphy of urinary tract infections. Infection 1990; 18 (Suppl 2): 53-6.
7. SCHAEFFER A.J.: The expanding role fluoroquinolones. Am J Med 2002; 113 Suppl 1A: 45S-54S
8. VAN BALEN F.A., TOUW-OTTEN F.W., DE MELKER R.A. Single-dose pefloxacin versus five-days treatment with norfloxacin in uncomplicated cystitis in women. J Antimicrob Chemoter 1990; 26: 153-60
9. AUQUER F., CORDON F., GORINA E., CABALLERO J.C., ADALID C., BATTLE J.: Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women. Clin Microbiol Infect 2002; 8: 50-4
10. NABER K.G.: Short-term therapy of acute uncomplicated cystitis. Curr Opin Urol 1999; 9(1): 57-64
11. GRASSI C., SALVATORI E., ROSIGNOLI M.T., DIONISIO P.: Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis. Respiration 2002; 69(3): 217-22
12. OZAKI M., MATSUDA M., TOMMII Y., KIMURA K., KAZUNO K., KITANO M.: In vitro antibacterial activity of a new quinolone, NM394. Antimicrob Agents Chemother 1991; 35: 2490-5
13. YOSHIDA T., MITSUHASHI S.: Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone. Antimicrob Agents Chemother 1993; 37: 793-800
14. MONTANARI M.P., MINGOIA M., VARALDO P.E.: In vitro antibacterial activity of AF3013, the active metabolite of prulifloxacin against nosocomial and community Italian isolates. Antimicrob Agents Chemother 2001; 45(12): 3616-22
15. TOUGOU K., NAKAMURA A., WATANABE S., OKUYAMA Y., MORINO A.: Paraxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent. Drug Metab Dispos 1998; 26: 355-59
16. RUBIN R.H., SHAPIRO E.D., ANDRIOLE V.T., DAVIS R.J., STAMM W.E.: Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992; 15 Suppl 1: S216-27
17. KUNIN C.M.: Guidelines for the evaluation of new anti-infective drugs for the treatment of urinary tract infection: additional considerations. Clin Infect Dis 1992; 15(6): 1041-4
18. NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARD: Performance Standards for Antimicrobial Disk Susceptibility Tests. Sixth Edition: Approved Standard M2-A6. NCCLS Wayne, Pennsylvania, 1997
19. COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS: Points to consider on switching between superiority and non-inferiority. CPMP/EWP/482/99, London, 27 July 2000
20. WAGENLEHNER F.M., NABER K.G.: Uncomplicated urinary tract infections in women. Curr Opin Urol 2001; 11(1):49-53
21. GUPTA K., HOOTON T.M., STAMM W.E.: Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001; 135(1):41-50
22. RICHARD G.A., MATHEW C.P., KIRSTEIN J.M., ORCHARD D., YANG J.Y.: Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens. Urology 2002; 59(3):334-9
23. WARREN J.W., ABRUTYN E., HEBEL J.R., JOHNSON J.R., SCHAEFFER A.J., STAMM W.E.: Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999; 29(4):745-58